Pharmaceuticals - Community Register


Community list of not active medicinal products for human use


Product information

Invented name: Uprima
Auth. number : EU/1/01/180
Active substance : apomorphine hydrochloride
ATC: Anatomical main group: G - Genito urinary system and sex hormones
Therapeutic subgroup: G04 - Urologicals
Pharmacological subgroup: G04B - Other urologicals, including antispasmodics
Chemical subgroup: G04BE - Drugs used in erectile dysfunction
Chemical substance: G04BE07 - apomorphine
(See WHO ATC Index)
Indication: Treatment of erectile dysfunction
Marketing Authorisation Holder: Abbott Laboratories Ltd
Abbott House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire SL6 4XE, United Kingdom
EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/05/2001 Centralised - Authorisation EMEA/H/C/327 (2001)1253 of 28/05/2001
16/04/2002 Centralised - Notification EMEA/H/C/327/N/2 (2002)1468 of 12/04/2002
19/05/2003 Centralised - Variation EMEA/H/C/327/II/3 (2003)1678 of 15/05/2003
29/01/2004 Centralised - Variation EMEA/H/C/327/II/4 (2004)217 of 27/01/2004
18/06/2004 Centralised - Notification EMEA/H/C/327/N/5
Updated with Decision(2005)1059 of 29/03/2005
13/12/2004 Centralised - Variation (no change in Commission Decision) EMEA/H/C/327/IA/6
31/03/2005 Centralised - Variation EMEA/H/C/327/II/7 (2005)1059 of 29/03/2005
28/05/2006 Centralised - Withdrawal (not renewed)